Hot Stocks: Brokerage view on Infosys, HDFC Bank, Piramal Pharma and Indigo
HDFC Bank, Kotak Mahindra Bank has a buy rating on InterGlobe Aviation, Jefferies recommended a buy on Piramal Pharma and UBS maintained a buy on Infosys.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
<div data-placement=«Mid Article Thumbnails» data-target_type=«mix» data-mode=«thumbnails-mid» style=«min-height:400px; margin-bottom:12px;» class=«wdt-taboola» id=«taboola-mid-article-thumbnails-108604300»>Nomura on HDFC Bank: Neutral| Target Rs 1625
Nomura maintained a neutral rating on HDFC Bank with a target price of Rs 1625. HDFC Bank has a significant depth in senior management, which it has demonstrated in the past as well.
The global investment bank does not expect any material impact on the business owing to this change in senior management.
“Any similar churn at the senior management level over the near-to-medium term will be a key monitorable,” said the note.
Kotak Mahindra Bank on InterGlobe Aviation: Buy| Target Rs 4200
Kotak Mahindra Bank maintained a buy rating on InterGlobe Aviation but raised the target price to Rs 4200 from Rs 3700 earlier.
Boeing could meaningfully limit the capacity addition of peers over time. The real demand is not served fully by supply and will grow at a healthy pace.
IndiGo to benefit from timely orders of past and healthy pricing ahead. Pricing would likely remain healthy over time and less prone to irrationality by airlines.
UBS on Infosys: Buy| Target Rs 1800
UBS maintained a buy rating on Infosys with a target price of Rs 1800. Q4 earnings may have a modest impact on its stock price, given the narrow range of expectations.
The global investment bank expects conservative guidance for FY25. The guidance range of
